Pfizer Approvals Don’t Quit: Chantix Clears FDA For Smoking Cessation
This article was originally published in The Pink Sheet Daily
Executive Summary
Advantage of varenicline over GSK’s Zyban is more pronounced over the short-term than long-term.
You may also be interested in...
NICE Recommends Cost Effectiveness Of Pfizer’s Smoking Cessation Drug
Varenicline is superior to nicotine replacement therapy and bupropion in achieving continuous abstinence, NICE determines.
NICE Recommends Cost Effectiveness Of Pfizer’s Smoking Cessation Drug
Varenicline is superior to nicotine replacement therapy and bupropion in achieving continuous abstinence, NICE determines.
Two Nicotine Addiction Vaccines On Phase III Racetrack
Novartis partners with Cytos on CYT002-NicQb, while Nabi looks to partner NicVax prior to pivotal trials in second half.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: